Latest Breaking News On - Oncology service - Page 1 : comparemela.com

Dr Devoe on Safety and Efficacy Data for ELI-002 7P in KRAS+, MRD+ PDAC and CRC

Craig E. Devoe, MD, MS, discusses data for ELI-002 7P in patients with MRD-positive pancreatic and colorectal cancers after locoregional therapy.

Tony Teramana Cancer Center marks National Cancer Survivors Day with hope and support

Trinity Health System's Tony Teramana Cancer Center celebrated National Cancer Survivors Day by honoring the strength and resilience of those affected by cancer

Aura Biosciences to Host Virtual KOL Event "Pioneering a New Standard of Care In Ocular Oncology" on May 29, 2024

Trastuzumab Plus Pertuzumab Provides Sustained iDFS Benefit in HER2+ Breast Cancer

A chemotherapy-free regimen of trastuzumab plus pertuzumab generated a strong 3-year iDFS rate in patients with HER2-positive early breast cancer.

Breast Cancer : 4,500 New Cases Registered Yearly

Surgery, chemo and radiation therapeutic treatments are available in some hospitals with a relative low success rate due to the advanced stages of the cancer cells.